Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.72
-0.03-1.71%
Last update: Oct 14, 7:51 PM
$1.72
-0.026-1.49%
Acrivon Therapeutics Inc (ACRV) Stock Price, Quote, News & History
ACRVNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.
Other companies in Acrivon Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Acrivon Therapeutics has a consensus price target of $17.75.
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $1.724 last updated October 14, 2026 at 7:51 PM EDT.
There are no upcoming dividends for Acrivon Therapeutics.
Acrivon Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Acrivon Therapeutics.
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
